ENTRADA THERAPEUTICS INC. - COMMON STOCK
13.17
14-February-25 11:18:59
15 minutes delayed
Stocks
+0.54
+4.27%
Today's range
12.66 - 13.40
ISIN
N/A
Source
NASDAQ
-
Entrada Therapeutics to Present at Goldman Sachs Global Healthcare Conference
01 Jun 2022 06:00:02 By Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports First Quarter 2022 Financial Results
12 May 2022 06:00:01 By Nasdaq GlobeNewswire
-
11 May 2022 08:30:00 By Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at H.C. Wainwright Global Investment Conference
10 May 2022 06:00:03 By Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
15 Mar 2022 06:00:01 By Nasdaq GlobeNewswire
-
Entrada Therapeutics to Participate in Cowen 42nd Annual Health Care Conference
23 Feb 2022 07:00:02 By Nasdaq GlobeNewswire
-
Entrada Therapeutics Announces the Appointment of Jared Cohen, PhD, JD to General Counsel
05 Jan 2022 07:00:03 By Nasdaq GlobeNewswire
-
Entrada Therapeutics to be Added to Russell 2000® and Russell 3000® Indexes
17 Dec 2021 07:00:00 By Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports Third Quarter 2021 Financial Results
09 Dec 2021 06:00:00 By Nasdaq GlobeNewswire